معرفی
Craig A. Bunnell is an Associate Professor of Medicine at Harvard Medical School and the Morse Family Chief Medical Officer of the Dana-Farber Cancer Institute, a Harvard-affiliated NCI-designated Comprehensive Cancer Center. He is a breast medical oncologist with expertise in clinical trials, cancer care delivery, and healthcare systems innovation.
- MD and PhD in Medicine from Harvard Medical School
- MBA from Massachusetts Institute of Technology
- Completed residency and fellowship at Brigham and Women's Hospital
His research focuses on novel agents for breast cancer, chemotherapy safety, and operational efficiency in oncology. He pioneered trastuzumab-vinorelbine combination therapy for HER2-positive breast cancer and conducted foundational work on weekly taxane regimens. Current studies include DPYD testing for fluoropyrimidine safety and multidisciplinary care pathways.
Scientific contributions span 120+ publications in areas like symptom control, genomic testing, and healthcare technology implementation. Notable awards include the Bass Scholar distinction (2000) and Boston Business Journal's Champion in Healthcare (2010) for industry innovation.
Leadership roles include positions at the National Comprehensive Cancer Centers, American Society of Clinical Oncology, and Association of American Cancer Institutes. He has developed real-time locating systems (RTLS) for clinic optimization and studied patient compliance with oral chemotherapies.
